Current Opinion in Gastroenterology was launched in 1985. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of gastroenterology is divided into 12 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Editor and Section Editors for this issue.
Ciarán P. Kelly
Ciarán P. Kelly, MD, is Professor of Medicine at Harvard Medical School, Director of Gastroenterology Training and Medical Director of the Celiac Center at Beth Israel Deaconess Medical Center, Boston, Massachussets, USA. Dr Kelly earned his medical degree from Trinity College in Dublin, Ireland where he was a foundation scholar and recipient of numerous academic awards. Dr Kelly has also received postgraduate clinical and research awards from the Crohn's and Colitis Foundation of America, the American Gastroenterological Association and the National Institutes of Health. He is an American Gastroenterology Association Fellow and a Fellow of the American College of Gastroenterology.
Dr Kelly has longstanding clinical and research interests in intestinal infection and inflammation. He has been involved in patient care and research in Clostridium difficile infection for more than 20 years and leads NIH-funded research programs that evaluate potential C. difficile vaccines and other immune-based treatments. His interest in the pathophysiology, diagnosis and management of celiac disease is also longstanding and, as Medical Director of the Celiac Center at BIDMC which he founded in 2004, he heads clinical, research and educational programs in celiac disease.
Dr Kelly has served as a committee member of the NIH, Center for Scientific Review as well as FDA, CDC and NIH committees on celiac disease and C. difficile infection. Dr Kelly is the author of more than 200 clinical and basic research book chapters, invited reviews, and peer-reviewed, original articles appearing in such journals as Infection & Immunity, American Journal of Physiology, Gastroenterology, Journal of Biological Chemistry, Journal of Clinical Investigation, New England Journal of Medicine and Lancet.
Mitchell B. Cohen
Mitchell B. Cohen, MD, is the Katherine Reynolds Ireland Chair in Pediatrics and Professor and Chair of Pediatrics at the University of Alabama at Birmingham. He is Physician-in-Chief of Children's of Alabama.
Dr Cohen has had a long-standing interest in the pathophysiology of diarrheal diseases and continues to direct research programs related to intestinal secretion and infection. These programs include studies of the guanylin family of intestinal peptides, epidemiology and pathogenesis of diarrheagenic E. coli and studies of human cholera and typhoid fever vaccines.
Dr Cohen was formerly the Director of Gastroenterology, Hepatology & Nutrition and Vice-Chair of Pediatrics for Clinical Affairs at Cincinnati Children's. He was also the Director of the NIDDK-funded Silvio O. Conte Digestive Diseases Research Core Center (DDRCC) entitled Digestive Health Center (DHC): Bench-to-Bedside Research in Pediatric Digestive Disease and the director of the NIH-funded Fellowship Training Program in Pediatric Gastroenterology.
Dr Cohen is active in the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) where he has served as president. He is also active in the American Gastroenterological Association, where he served as chair of the section on Growth Development and Nutrition. He has served as a member of the Clinical Research Committee of the Cystic Fibrosis Foundation (CFFTI), and a number of NIH study sections and the National Commission on Digestive Diseases. He was the recipient of the 2013 Shwachman Award from the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition.
Eamonn M.M. Quigley
Eamonn M.M. Quigley is Chief of Gastroenterology at The Methodist Hospital in Houston, Texas, USA, and a Principal Investigator at the Alimentary Pharmabiotic Centre (APC) at University College Cork (UCC), in Cork, Ireland. A graduate of UCC, Dr Quigley trained in internal medicine in Glasgow and Manchester and in gastroenterology in Glasgow, the Mayo Clinic, USA, Rochester, Minnesota and Manchester. In 1986 he joined the faculty at the University of Nebraska Medical Center in Omaha, Nebraska, USA, where he ultimately served as Chief of Gastroenterology and Hepatology. Returning to Cork in 1998 he served as Dean of the Medical School at UCC for 7 years and has been a principal investigator at the APC since its inception. He took up his current position in January 2013. He served as president of both the American College of Gastroenterology and the World Gastroenterology Organisation and is a past editor-in-chief of the American Journal of Gastroenterology. Clinical and research interests include irritable bowel syndrome, gastrointestinal motility and the role of the gut microbiota in health and in gastrointestinal and metabolic disorders.